Related Experiment Video
Updated: Dec 10, 2025
11:02
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
911
Anabolic steroids-induced delirium: A case report
Mohamed Adil Shah Khoodoruth1, Adeel Ahmad Khan2
1Chief Psychiatry Resident, Department of Psychiatry.
Medicine
|September 3, 2020
Summary
Anabolic steroid abuse can cause delirium, aggression, and hostility. This case report highlights the neuropsychiatric effects of anabolic steroids and their successful management with antipsychotic medications.
Area of Science:
- Neuropsychiatry
- Endocrinology
- Toxicology
Background:
- Anabolic-androgenic steroids (AAS) are frequently misused by athletes and bodybuilders for performance enhancement.
- While physical health risks are known, the psychiatric and neuropsychiatric effects of AAS are critically important.
- Reported psychiatric effects include psychosis, mania, depression, aggression, and delirium.
Observation:
- A 33-year-old male presented with severe aggression, hostility, and destructive impulses.
- He reported daily use of injectable testosterone propionate, testosterone cypionate, and trenbolone acetate.
- Examination revealed atrophic testes and low plasma testosterone levels, indicative of exogenous steroid impact.
Findings:
- The patient was diagnosed with anabolic steroid-induced delirium.
- Mental status examination showed emotional lability, flight of ideas, and persecutory delusions.
- Laboratory results confirmed suppressed endogenous testosterone production.
Implications:
- This case underscores the significant neuropsychiatric risks associated with anabolic steroid misuse.
- Prompt diagnosis and management with antipsychotic medications (haloperidol, quetiapine) led to clinical improvement.
- Emphasizes the need for increased awareness among healthcare providers regarding AAS-related psychiatric complications.
More Related Videos
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
464
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
464
01:28Psychosis and Antipsychotic Drugs: Overview
670
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
670
01:27Adrenal Gland Disorders
2.7K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.7K
01:26Psychosis: Goals of Pharmacotherapy
359
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
359
01:29Drugs Affecting Neurotransmitter Synthesis
1.9K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.9K
01:23Drugs Acting on Autonomic Ganglia: Stimulants
1.9K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.9K